The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America
Open accessAbstract
BACKGROUND: Cardiovascular disease and non-AIDS malignancies have become major causes of death among HIV-infected individuals. The relative impact of lifestyle and HIV-related factors are debated. METHODS: We estimated associations of smoking with mortality more than 1 year after antiretroviral therapy (ART) initiation among HIV-infected individuals enrolled in European and North American cohorts. IDUs were excluded. Causes of death were assigned using standardized procedures. We used abridged life tables to estimate life expectancies. Life-years lost to HIV were estimated by comparison with the French background population. RESULTS: Among 17,995 HIV-infected individuals followed for 79,760 person-years, the proportion of smokers was 60%. The mortality rate ratio (MRR) comparing smokers with nonsmokers was 1.94 [95% confidence interval (95% CI) 1.56-2.41]. The MRRs comparing current and previous smokers with never smokers were 1.70 (95% CI 1.23-2.34) and 0.92 (95% CI 0.64-1.34), respectively. Smokers had substantially higher mortality from cardiovascular disease, non-AIDS malignancies than nonsmokers [MRR 6.28 (95% CI 2.19-18.0) and 3.31 (95% CI 1.80-5.45), respectively]. [corrected]. Among 35-year-old HIV-infected men, the loss of life-years associated with smoking and HIV was 7.9 (95% CI 7.1-8.7) and 5.9 (95% CI 4.9-6.9), respectively. The life expectancy of virally suppressed, never-smokers was 43.5 years (95% CI 41.7-45.3), compared with 44.4 years among 35-year-old men in the background population. Excess MRRs/1000 person-years associated with smoking increased from 0.6 (95% CI -1.3 to 2.6) at age 35 to 43.6 (95% CI 37.9-49.3) at age at least 65 years. CONCLUSION: Well treated HIV-infected individuals may lose more life years through smoking than through HIV. Excess mortality associated with smoking increases markedly with age. Therefore, increases in smoking-related mortality can be expected as the treated HIV-infected population ages. Interventions for smoking cessation should be prioritized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PLWH who smoke (SLWH) lose more life-years than PLWH who do not smoke and people who smoke who do not have HIV.3–5”
From Evaluation of an integrated treatment to address smoking cessation and anxiety/depressive symptoms among people living with HIV: Study protocol for a randomized controlled trial (2021) · cites this paper as [4]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
21st-Century Hazards of Smoking and Benefits of Cessation in the United States
Jha, P., Ramasundarahettige, C., Landsman, V., Rostron, B., Thun, M., Anderson, R. N., McAfee, T., & Peto, R. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1211128 · Cited by 1,767 · cited 1×
“has been found in HIV-negative populations [33].”
. Survival of persons with and without HIV infection in Denmark, 1995-2005.
Lohse, N., Hansen, A.-B. E., Pedersen, G., Kronborg, G., Gerstoft, J., Sørensen, H. T., Væth, M., & Obel, N. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00003 · Cited by 748
Self-citationMorbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study
Hasse, B., Ledergerber, B., Furrer, H., Battegay, M., Hirschel, B., Cavassini, M., Bertisch, B., Bernasconi, E., Weber, R., & Study, T. S. H. C. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir626 · Cited by 608
Self-citation(2010) · Clinical Infectious Diseases · doi:10.1086/652283 · Cited by 594
Helleberg, M., Afzal, S., Kronborg, G., Larsen, C. S., Pedersen, G., Pedersen, C., Gerstoft, J., Nordestgaard, B. G., & Obel, N. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis933 · Cited by 463
Self-citationSackoff, J. E., Hanna, D. B., Pfeiffer, M. R., & Torian, L. V. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-6-200609190-00003 · Cited by 451
Projected life expectancy of people with HIV according to timing of diagnosis
Nakagawa, F., Lodwick, R. K., Smith, C. J., Smith, R., Cambiano, V., Lundgren, J. D., Delpech, V., & Phillips, A. N. (2012) · AIDS · doi:10.1097/qad.0b013e32834dcec9 · Cited by 443
Self-citation
Cited by
Marcus, J. L., Chao, C. R., Leyden, W. A., Xu, L., Quesenberry, C. P., Klein, D. B., Towner, W. J., Horberg, M. A., & Silverberg, M. J. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001014 · Cited by 439
Teeraananchai, S., Kerr, S., Amin, J., Ruxrungtham, K., & Law, M. (2017) · HIV Medicine · doi:10.1111/hiv.12421 · Cited by 433
Reddy, K. P., Parker, R. A., Losina, E., Baggett, T. P., Paltiel, A. D., Rigotti, N. A., Weinstein, M. C., Freedberg, K. A., & Walensky, R. P. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw430 · Cited by 135
Frazier, E. L., Sutton, M. Y., Brooks, J. T., Shouse, R. L., & Weiser, J. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.03.007 · Cited by 103
Tseng, T.-Y., Krebs, P., Schoenthaler, A., Wong, S., Sherman, S., Gonzalez, M., Urbina, A., Cleland, C. M., & Shelley, D. (2017) · AIDS and Behavior · doi:10.1007/s10461-016-1538-z · Cited by 69
Metadata
- Authors
- Helleberg, M., May, M. T., Ingle, S. M., Dabis, F., Reiss, P., Fätkenheuer, G., Costagliola, D., d’Arminio, A., Cavassini, M., Smith, C., Justice, A. C., Gill, J., Sterne, J. A. C., & Obel, N.
- Affiliations
- University of Copenhagen (DK)
- University of Bristol (GB)
- Amsterdam UMC Location University of Amsterdam (NL)
- University of Cologne (DE)
- Inserm (FR)
- Centre Hospitalier Universitaire Vaudois (CH)
- University College London (GB)
- Yale University (US)
- Corresponding author
- Helleberg, Marie
- ORCID
- Venue
- AIDS
- Published
- 2015-01-14
- Volume
- 29
- Issue
- 2
- Pages
- 221-229
- ISSN
- 0269-9370 (ISSN-L)
- PMC
- PMC4284008
- OpenAlex
- W1993551104
- Semantic Scholar
- e38b0b10acc2943618d9ddaf790c45366b75d5e0
- Cited by
- 268
- References
- 34
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 21 · 2023: 12 · 2022: 19 · 2021: 19 · 2020: 33 · 2019: 26 · 2018: 30 · 2017: 38 · 2016: 30 · 2015: 13
- FWCI
- 28.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- AIDS (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- IRIS (submittedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Bristol Research (University of Bristol) (submittedVersion, cc-by-nc-nd)
- SERVAL (Université de Lausanne) (submittedVersion, other-oa)
- Funders
- National Science Foundation
- U.S. Department of Veterans Affairs
- Bristol-Myers Squibb
- Pfizer
- Styrelsen för Internationellt Utvecklingssamarbete
- Gilead Sciences
- Office of Research and Development
- ViiV Healthcare
- Michael Smith Health Research BC
- National Institute for Health and Care Research (NF-SI-0611-10168)
- Institut National de la Santé et de la Recherche Médicale
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (134277)
- Department for International Development
- Stichting HIV Monitoring
- Canadian Institutes of Health Research (U24-AA020794)
- Medical Research Council (MR/J002380/1)
- National Institute on Alcohol Abuse and Alcoholism (U01AA020790, U10AA013566, U24AA020794)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- smoking, HIV infection, antiretroviral therapy, life expectancy, mortality, cardiovascular disease, years of life lost, smoking cessation, HIV mortality, lifestyle risk factors, viral suppression, abridged life tables, mortality rate ratio, age-specific mortality risk, tobacco control
- MeSH terms
- Adult, Europe, Female, Humans, Life Expectancy, Male, Middle Aged, North America, Smoking, Cohort Studies, HIV Infections, CD4 Lymphocyte Count, Antiretroviral Therapy, Highly Active
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. https://app.cochat.ai/papers/10.1097/qad.0000000000000540
- The paper
- Helleberg, M., May, M. T., Ingle, S. M., Dabis, F., Reiss, P., Fätkenheuer, G., Costagliola, D., d’Arminio, A., Cavassini, M., Smith, C., Justice, A. C., Gill, J., Sterne, J. A. C., & Obel, N. (2015). Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS. https://doi.org/10.1097/qad.0000000000000540
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
